November 18th, 2023

October 30th, 2023Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma Jun Qin,1 Irfan Shaukat,1 Didier Mainard,1 Patrick Netter,1 Lydia Barré,1 and Mohamed Ouzzine1 Author...

October 29th, 2023Chondrosarcoma Patient Registry https://chondrosarcoma.iamrare.org On November 30 the Chondrosarcoma will conduct the first full statistical analysis of the Chondrosarcoma Patient Registry. The analysis will focus on detailed patient profiling. In...

October 27th, 2023Videos from Virtual Dialogue 5 are posted on the Web Site. We invite you to go to the Chondrosarcoma Foundation web site to review the presentations and the open discussion from the Fifth International Virtual Dialogue recently held on October 4....

October 26th, 2023New Publication: Chondrosarcoma: What You Need to Know A third publication created by the Chondrosarcoma Foundation's Patient, Family, Caregiver Advisory Board and the Marketing / Graphics team at Inhibrx provides straightforward information on...

October 8th, 2023Steppin' For A Cause: 5K Walk / Run October 21, 2023 10:00AM EST Allen's Pond, Bowie, Maryland Please join us for our annual fund raising event to honor Shayna Kramer by carrying out her wish to help others that have the same rare bone cancer:...

October 1st, 2023Future Initiatives in the Diagnosis and Treatment of Chondrosarcoma Chondrosarcoma Foundation: Fifth International Virtual Dialogue (VIA Zoom) Date: Wednesday, October 4, 2023 Time: 7:00PM – 9:00PM (EST / New York) Last chance to register. The...

September 30th, 2023Paper recently published in Clinical Cancer Research on genetic sequencing of conventional and dedifferentiated chondrosarcoma from two of our board members at MD Anderson in Houston, Texas: Anthony Conley, M.D. and Shaan Mohahmad Razza, M.D. For...